1 Healthcare Stock with Competitive Advantages and 2 We Find Risky Radek Strnad Wed, October 7, 2026 at 4:56 AM EDT 3 min read DHR -2.53% ^GSPC +0.58% PFE +0.33% ITGR +0.02% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 36.4% gain over the past six months, beating the S&P 500 by 18.9 percentage points.
Regardless of these results, investors must exercise caution as many businesses in this space are subject to heavy regulation that can influence their earnings potential. With that said, here is one healthcare stock boasting a durable advantage and two that may face trouble.
Born from a real estate investment trust that transformed into a manufacturing powerhouse, Danaher (NYSE:DHR) is a global science and technology company that provides specialized equipment, software, and services for biotechnology, life sciences, and diagnostics.
Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
Expenses have increased as a percentage of revenue over the last five years as its adjusted operating margin fell by 7.8 percentage points
Performance over the past five years shows each sale was less profitable, as its earnings per share fell by 1.6% annually
Danaher is trading at $216.14 per share, or 25x forward P/E. Check out our free in-depth research report to learn more about why DHR doesn't pass our bar.
With its name reflecting the mathematical term for "whole" or "complete," Integer Holdings (NYSE:ITGR) is a medical device outsource manufacturer that produces components and systems for cardiac, vascular, neurological, and other medical applications.
Sales trends were unexciting over the last two years as its 6.1% annual growth was below the typical healthcare company
Revenue base of $1.84 billion puts it at a disadvantage compared to larger competitors exhibiting economies of scale
Estimated sales growth of 1.5% for the next 12 months implies demand will slow from its two-year trend
Integer Holdings's stock price of $126.48 implies a valuation ratio of 18.9x forward P/E. Read our free research report to see why you should think twice about including ITGR in your portfolio, it's free.
With roots dating back to 1849 when two German immigrants opened a fine chemicals business in Brooklyn, Pfizer (NYSE:PFE) is a global biopharmaceutical company that discovers, develops, manufactures, and sells medicines and vaccines for a wide range of diseases and conditions.
Massive revenue base of $63.7 billion in a highly regulated sector makes the company difficult to replace, giving it meaningful negotiating power
Adjusted operating profits increased over the last two years as the company gained some leverage on its fixed costs and became more efficient
Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures
At $27.50 per share, Pfizer trades at 9.9x forward P/E. Is now the right time to buy? Find out in our full research report, it's free.
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
